Findings

What do systematic reviews say?

4,695 questions · 4,979 findings · 433 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 998 · 20%GRADE not reported 1,140 · 22.9%Very low 1,024 · 20.6%Low 1,029 · 20.7%Moderate 636 · 12.8%High 152 · 3.1%

Non‐nutritive sucking (NNS) vs no NNS

Postconceptual age at full oral feeds (days) · preterm infants

1 finding from 1 review

Non‐nutritive sucking for increasing physiologic stability and nutrition in preterm infants 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 28 participants
Very low

Bisphosphonates vs control

Femoral neck bone mineral density (FN-BMD) · adults with GIOP

1 finding from 1 review

Bisphosphonates for steroid‐induced osteoporosis 2016 · Cochrane Headline outcomes only
no estimate extracted
18 studies · 1665 participants
Moderate

Corticosteroids vs control

Improvement in disability grade after 4 weeks · patients with Guillain‐Barré syndrome

1 finding from 1 review

Corticosteroids for Guillain‐Barré syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 120 participants
Very low

Antioestrogen plus medical adjunct vs antioestrogen

Miscarriage · ovulation induction in polycystic ovarian syndrome

1 finding from 1 review

Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

LASB vs oral corticosteroids · adults with CRPS

1 finding from 1 review

Local anaesthetic sympathetic blockade for complex regional pain syndrome 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 38 participants
Very low

Action plan vs usual care

Courses of oral corticosteroids · acute exacerbations of chronic obstructive pulmonary disease

1 finding from 1 review

Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 200 participants
Moderate

Responsive vs scheduled feeding

Time to establishment of full oral feeds (after trial entry) · preterm infants

1 finding from 1 review

Responsive versus scheduled feeding for preterm infants 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 167 participants
Low

Very early discharge vs early discharge

Duration of oral antimicrobial treatment · children with cancer

Very early discharge may leads to lower duration of oral antimicrobial treatment compared with early discharge (low certainty).

1 finding from 1 review

Very early discharge versus early discharge versus non‐early discharge in children with cancer and febrile neutropenia 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Early discharge vs non‐early discharge

Duration of oral antimicrobial treatment · children with cancer

1 finding from 1 review

Very early discharge versus early discharge versus non‐early discharge in children with cancer and febrile neutropenia 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

OC: oral contraceptive · perimenopausal women with need for contraception

The review found no eligible studies for this question.

1 finding from 1 review

Progestin‐only contraceptives: effects on weight 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings for all doses of nasal decongestant vs placebo

Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold

1 finding from 1 review

Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 85 participants
Low

Summary of findings for all doses of nasal decongestant vs placebo

Primary outcome: subjective symptom score (AUC) ‐ 3 hours after dosingOral · adult patients with the common cold

1 finding from 1 review

Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 260 participants
Low

Summary of findings for multi‐dose nasal decongestant vs placebo

Primary outcome: subjective symptom score (mean) ‐ 3 hours after dosing · adult patients with the common cold

1 finding from 1 review

Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 33 participants
GRADE not reported

Summary of findings for multi‐dose nasal decongestant vs placebo

Secondary outcome: all adverse eventsOral · adult patients with the common cold

Summary of findings for multi‐dose nasal decongestant showed no clear difference in secondary outcome: all adverse eventsOral compared with placebo (low certainty).

1 finding from 1 review

Nasal decongestants in monotherapy for the common cold 2016 · Cochrane Headline outcomes only
OR 0.95 [0.65, 1.39]
6 studies · 1134 participants
Low

Intervention not reported

Behavioral problems ‐ Parental ATEC score · children with ASD

1 finding from 1 review

Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Intervention not reported

Behavioral problems ‐ Clinician ATEC score (scale from 0 to 40) · children with ASD

1 finding from 1 review

Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD) 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Therapeutic swallowing exercises vs sham

Adverse events: Dysphagia‐related complications Occurrence of dysphagia‐related complications: pneumonia, dehydration, mucositis and oral yeast infection · adults with advanced head and neck cancer

1 finding from 1 review

Therapeutic exercises for affecting post‐treatment swallowing in people treated for advanced‐stage head and neck cancers 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low

Intervention not reported

Exacerbations requiring oral corticosteroids 7.3‐month · people with asthma

The intervention showed no clear difference in exacerbations requiring oral corticosteroids 7.3‐month (low certainty).

1 finding from 1 review

Home telemonitoring and remote feedback between clinic visits for asthma 2016 · Cochrane Headline outcomes only
OR 0.93 [0.6, 1.44]
4 studies · 466 participants
Low

Intervention not reported

Exacerbations requiring oral corticosteroids3 months · adults or children with asthma

The intervention showed no clear difference in exacerbations requiring oral corticosteroids3 months (low certainty).

1 finding from 1 review

Remote versus face‐to‐face check‐ups for asthma 2016 · Cochrane Headline outcomes only
OR 1.74 [0.41, 7.44]
1 study · 278 participants
Low

Intervention not reported

Exacerbations requiring oral corticosteroids 48 weeks · adults with asthma

The intervention showed no clear difference in exacerbations requiring oral corticosteroids 48 weeks (moderate certainty).

1 finding from 1 review

Long‐acting muscarinic antagonists (LAMA) added to combination long‐acting beta₂‐agonists and inhaled corticosteroids… 2016 · Cochrane Headline outcomes only
OR 0.76 [0.57, 1.02]
2 studies · 907 participants
Moderate